To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C19orf25TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
349 supporting clones for gene C19orf25 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM548033 brain, hippocampus .a 1 to 679 11 to 695 W7C G8F T26S E86Q K92E ... tiling clone,   685/1166
(58 %)
38 diff
(96.8 %id)
CR596309 HeLa cells Cot 25-normalized .a 44 to 1451 1 to 1408   tiling clone,   1408/1408
(100 %)
0 diff
(100 %id)
BX342278   .a 44 to 801 1 to 756   fully sequenced,   756/756
(100 %)
0 diff
(100 %id)
BG339138 leiomyosarcoma cell line, uterus .a 147 to 995 1 to 843       843/1088
(77 %)
23 diff
(97.9 %id)
BM548952 melanotic melanoma, skin .a 251 to 974 37 to 778       742/900
(82 %)
31 diff
(96.6 %id)
BX342277   .a 771 to 1450 679 to 1   fully sequenced,   679/679
(100 %)
10 diff
(98.6 %id)
CV419920 colon_normal .b-u 1 to 259 20 to 274   tiling clone,   255/282
(90 %)
8 diff
(97.2 %id)
DA957535 Spleen .b-u 42 to 589 2 to 549   tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
AW841505 colon_normal .b-u 517 to 691 1 to 175   tiling clone,   175/175
(100 %)
1 diff
(99.5 %id)
BI008749 kidney_tumor .b-u 626 to 1141 15 to 527   tiling clone,   513/527
(97 %)
9 diff
(98.3 %id)
BQ437312 melanotic melanoma, skin .b-u 1124 to 1745 1 to 621   tiling clone,   621/643
(96 %)
4 diff
(99.4 %id)
BF354281 head_neck .b-u 1160 to 1404 251 to 1       251/266
(94 %)
11 diff
(95.9 %id)
CN294998 embryonic stem cells, DMSO-treated H9 cellline .b-u 1201 to 1410 1 to 210       210/210
(100 %)
1 diff
(99.6 %id)
CR996606 T-Lymphocytes .c-u 1 to 562 1 to 563 W6L A7G G9R A10S A11S ... tiling clone,   563/564
(99 %)
2 diff
(99.7 %id)
CN267842 embryonic stem cells, cell lines H1, H7, andH9 .c-u 472 to 1162 1 to 692   tiling clone,   692/692
(100 %)
6 diff
(99.2 %id)
CB105025 stomach .d 1 to 345 1 to 345   tiling clone,   345/345
(100 %)
1 diff
(99.8 %id)
DC297961   .d 3 to 555 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
BQ067925 brain .d 30 to 821 21 to 816 E141Q E143D Q146P A150G     796/1071
(74 %)
23 diff
(97.9 %id)
DA792196 brain .d 316 to 871 2 to 558   capped   557/557
(100 %)
6 diff
(99.0 %id)
BP210473 cerebellum .d 330 to 907 1 to 578   tiling clone,   578/578
(100 %)
1 diff
(99.9 %id)
CB106842 Liver .d 330 to 681 1 to 352       352/352
(100 %)
0 diff
(100 %id)
NM_152482.2   .d 330 to 2585 1 to 2256   RefSeq, AAA   2256/2256
(100 %)
0 diff
(100 %id)
DA275014 corpus callosum .d 331 to 884 2 to 556   capped   555/555
(100 %)
3 diff
(99.5 %id)
DA377642 thalamus .d 331 to 869 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA252737 caudate nucleus .d 332 to 884 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DA638800 Liver .d 334 to 875 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
DA901731   .d 334 to 852 2 to 522   capped   521/521
(100 %)
2 diff
(99.7 %id)
DA534143 brain .d 341 to 903 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BP216237 corpus callosum .d 344 to 927 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DB262937 uterus .d 344 to 836 2 to 494   capped   493/493
(100 %)
1 diff
(99.8 %id)
DA700682   .d 345 to 871 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
DA010193 adrenal gland .d 346 to 900 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA163043 amygdala .d 346 to 909 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA355841 subthalamic nucleus .d 346 to 884 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
BP281484 bone marrow .d 346 to 933 1 to 588       588/589
(99 %)
1 diff
(99.9 %id)
CB128382 Liver .d 346 to 769 1 to 423       422/423
(99 %)
3 diff
(99.3 %id)
BP308099 brain .d 346 to 928 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BM785712 Ascites, stomach .d 346 to 810 1 to 465       465/465
(100 %)
0 diff
(100 %id)
BM857258 stomach .d 346 to 733 1 to 388       388/388
(100 %)
2 diff
(99.5 %id)
BM829628 stomach .d 346 to 622 1 to 280       280/280
(100 %)
7 diff
(97.5 %id)
DA907865   .d 346 to 1110 2 to 775   capped   774/776
(99 %)
16 diff
(98.0 %id)
BP347138 brain .d 346 to 927 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB112174 thymus .d 346 to 932 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
AK075267 thyroid gland .d 347 to 2585 1 to 2239   tiling clone, available from FLJ,   2239/2239
(100 %)
0 diff
(100 %id)
DA025657   .d 347 to 908 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA207553 brain .d 347 to 915 2 to 570   capped   569/570
(99 %)
1 diff
(99.9 %id)
DA311023 hippocampus .d 347 to 875 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA484229 brain .d 347 to 875 2 to 532   capped   531/531
(100 %)
2 diff
(99.7 %id)
DA532524 brain .d 347 to 908 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BP307023   .d 347 to 930 1 to 583       583/584
(99 %)
3 diff
(99.5 %id)
DA919950 small intestine .d 347 to 905 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DB269818 uterus .d 347 to 908 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA015043 adrenal gland .d 348 to 921 2 to 575   capped   574/575
(99 %)
2 diff
(99.7 %id)
DA506281 brain .d 348 to 788 2 to 442   capped   441/441
(100 %)
0 diff
(100 %id)
DA868660 Prostate .d 348 to 879 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA923103 small intestine .d 348 to 898 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DB166420 thyroid gland .d 348 to 1015 2 to 669   capped   668/670
(99 %)
3 diff
(99.6 %id)
DB182071 liver, tumor tissue .d 348 to 910 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BP196004 adrenal gland .d 350 to 934 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
DA286215 corpus callosum .d 350 to 841 2 to 492   capped   491/491
(100 %)
1 diff
(99.8 %id)
DB500374 hypothalamus .d 350 to 832 1 to 483       483/487
(99 %)
3 diff
(99.4 %id)
DA540506 lung .d 351 to 899 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
DA649791   .d 352 to 899 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA704413   .d 352 to 824 2 to 474   capped   473/473
(100 %)
0 diff
(100 %id)
DA936376 Spleen .d 352 to 954 2 to 604   capped   603/603
(100 %)
1 diff
(99.9 %id)
DA589999 lung .d 353 to 908 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BP309219 brain .d 353 to 934 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
DA353156 substantia nigra .d 354 to 908 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA816499   .d 354 to 931 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA983703 synovial membrane tissue from rheumatioidarthritis .d 354 to 917 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA985842 synovial membrane tissue from rheumatioidarthritis .d 354 to 928 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB102854 thymus .d 354 to 890 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
CA395975 eye, RPE/choroid .d 356 to 981 1 to 626       626/626
(100 %)
0 diff
(100 %id)
BQ231623 melanotic melanoma, skin .d 356 to 1187 1 to 840       840/884
(95 %)
17 diff
(98.1 %id)
BQ051821 blood, natural killer cells, cell line .d 357 to 1272 1 to 936       936/1078
(86 %)
36 diff
(96.7 %id)
CN358432 embryonic stem cells, cell lines H1, H7, andH9 .d 358 to 1013 1 to 658       658/658
(100 %)
6 diff
(99.1 %id)
AL122089 Kidney .d 359 to 2585 1 to 2227   available from DKFZ, AAA   2227/2227
(100 %)
3 diff
(99.9 %id)
CV808488 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 359 to 1135 1 to 780       780/871
(89 %)
12 diff
(98.7 %id)
BC018441 Liver, adenocarcinoma .d 360 to 1619 1 to 1260   available from MGC, AAA   1260/1260
(100 %)
0 diff
(100 %id)
BG250697 adenocarcinoma, cell line, Liver .d 360 to 1131 1 to 769       769/993
(77 %)
29 diff
(97.1 %id)
TI_154193392   .d 360 to 1336 50 to 1009       960/1050
(91 %)
26 diff
(97.6 %id)
CF130943 Chondrosarcoma Lung Metastasis cell lines, lung .d 361 to 1063 1 to 703       703/703
(100 %)
0 diff
(100 %id)
CB138420 Liver .d 362 to 970 1 to 610       610/610
(100 %)
4 diff
(99.4 %id)
BP318686 pericardium .d 362 to 941 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP347490 brain .d 362 to 942 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
DN997076 breast cancer, Mammary gland (cancer tissue) .d 362 to 786 9 to 433       425/433
(98 %)
6 diff
(98.7 %id)
DA701659   .d 363 to 832 2 to 472   capped   471/471
(100 %)
2 diff
(99.6 %id)
DB112187 thymus .d 363 to 933 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
CR987626 T-Lymphocytes .d 364 to 756 1 to 394       394/394
(100 %)
1 diff
(99.8 %id)
DB491113 hypothalamus .d 365 to 678 1 to 316       316/318
(99 %)
16 diff
(95.0 %id)
DB499946 hypothalamus .d 365 to 854 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
AW631095 2 pooled high-grade transitional celltumors, genitourinary tract .d 365 to 653 1 to 289       289/289
(100 %)
1 diff
(99.7 %id)
BU155959 melanotic melanoma, skin .d 365 to 1053 1 to 689       689/917
(75 %)
1 diff
(99.9 %id)
AA366972 Pancreas .d 366 to 595 1 to 230       230/230
(100 %)
2 diff
(99.2 %id)
DA956151 Spleen .d 366 to 855 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
AW960135   .d 367 to 878 1 to 512       512/512
(100 %)
11 diff
(97.9 %id)
BM547184 brain, hippocampus .d 373 to 1138 19 to 785       767/1103
(69 %)
19 diff
(98.3 %id)
BM562423 amelanotic melanoma, cell line, skin .d 374 to 1141 1 to 774       774/923
(83 %)
11 diff
(98.9 %id)
BM423861 amelanotic melanoma, cell line, skin .d 374 to 1282 1 to 925       925/1062
(87 %)
22 diff
(98.0 %id)
DA646994 mammary gland .d 375 to 1035 2 to 663   capped   662/662
(100 %)
1 diff
(99.9 %id)
DT217277 brain .d 376 to 1070 1 to 695       695/695
(100 %)
0 diff
(100 %id)
DB473284.
matches multiple genes
hippocampus .d 376 to 844 1 to 469     also hits gene APC2 469/469
(100 %)
4 diff
(99.2 %id)
BF204675 muscle, rhabdomyosarcoma .d 376 to 1015 1 to 639       639/1462
(43 %)
5 diff
(99.7 %id)
BI333332 cervical carcinoma cell line, cervix .d 377 to 735 1 to 358       358/358
(100 %)
6 diff
(98.4 %id)
DA699848   .d 377 to 872 2 to 498   capped   497/497
(100 %)
1 diff
(99.8 %id)
DA732908   .d 377 to 1068 2 to 699   capped   698/800
(87 %)
17 diff
(97.9 %id)
DB484285 hypothalamus .d 378 to 805 1 to 428       428/428
(100 %)
16 diff
(96.3 %id)
DA620802   .d 378 to 973 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA690117   .d 378 to 921 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA968082 stomach .d 378 to 936 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB009452 colon, tumor tissue .d 378 to 948 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA946140 Spleen .d 382 to 938 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BQ636726 eye, retina .d 383 to 971 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BI760435 pooled colon, kidney, stomach .d 385 to 1097 1 to 715       715/715
(100 %)
8 diff
(98.9 %id)
DN601593 human embryonic stem cells .d 385 to 1163 1 to 779       779/779
(100 %)
0 diff
(100 %id)
DN997435 breast cancer, Mammary gland (cancer tissue) .d 386 to 905 28 to 546       530/546
(97 %)
8 diff
(98.6 %id)
TI_57148289   .d 387 to 1097 30 to 742       723/742
(97 %)
12 diff
(98.4 %id)
BF725558 eye, Iris .d 389 to 874 1 to 486       486/486
(100 %)
0 diff
(100 %id)
BE298776 muscle, rhabdomyosarcoma .d 391 to 950 1 to 560       560/560
(100 %)
0 diff
(100 %id)
AY007120   .d 394 to 2585 1 to 2192   AAA   2192/2192
(100 %)
2 diff
(100.0 %id)
CR603275 Neuroblastoma Cot 25-normalized .d 394 to 1568 1 to 1175       1175/1175
(100 %)
0 diff
(100 %id)
BX375457 Neuroblastoma Cot 25-normalized .d 394 to 1064 1 to 669   fully sequenced,   669/669
(100 %)
0 diff
(100 %id)
AL555532 placenta .d 394 to 1291 1 to 896       896/896
(100 %)
3 diff
(99.7 %id)
CR616237 HeLa cells Cot 25-normalized .d 458 to 2532 1 to 2075       2075/2075
(100 %)
0 diff
(100 %id)
BF724242 eye, Iris .d 524 to 1045 1 to 522       522/522
(100 %)
0 diff
(100 %id)
BM043046 carcinoma, cell line, Prostate .d 536 to 1307 1 to 766       766/920
(83 %)
28 diff
(97.0 %id)
BM044213 carcinoma, cell line, Prostate .d 536 to 1347 1 to 810       810/810
(100 %)
3 diff
(99.7 %id)
BQ891673 carcinoma, cell line, Prostate .d 538 to 1415 1 to 885       885/893
(99 %)
17 diff
(98.1 %id)
BU152582 carcinoma, cell line, Prostate .d 538 to 1286 1 to 753       753/861
(87 %)
5 diff
(99.5 %id)
BP422201 small intestine .d 579 to 1092 1 to 514     Submitted on the opposite strand 514/514
(100 %)
0 diff
(100 %id)
BM551513 melanotic melanoma, skin .d 582 to 1436 1 to 862       862/1060
(81 %)
22 diff
(98.0 %id)
CN358430 embryonic stem cells, cell lines H1, H7, andH9 .d 586 to 1011 1 to 426       426/426
(100 %)
4 diff
(99.1 %id)
BM926989 brain .d 646 to 1401 1 to 760       760/1008
(75 %)
14 diff
(98.7 %id)
TI_149285406   .d 712 to 1613 985 to 93   AAA   893/1149
(77 %)
31 diff
(97.4 %id)
W31115 senescent fibroblast .d 736 to 1190 1 to 460   fully sequenced,   460/460
(100 %)
13 diff
(97.2 %id)
TI_149301373   .d 744 to 1619 916 to 54   AAA   863/947
(91 %)
14 diff
(98.6 %id)
BM920987 pooled brain, lung, testis .d 758 to 1605 16 to 863       848/1014
(83 %)
13 diff
(98.8 %id)
AA330788 embryo .d 820 to 1055 1 to 236       236/236
(100 %)
0 diff
(100 %id)
BM768794 stomach .d 829 to 1417 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BM769266 stomach .d 829 to 1466 1 to 638       638/638
(100 %)
0 diff
(100 %id)
BQ083736 stomach .d 829 to 1248 1 to 421       421/421
(100 %)
1 diff
(99.8 %id)
BU689905 Human Lung Epithelial cells, lung .d 836 to 1615 795 to 19   AAA   777/779
(99 %)
7 diff
(99.2 %id)
W23929 senescent fibroblast .d 845 to 1226 1 to 390       390/390
(100 %)
21 diff
(94.7 %id)
TI_149303871   .d 848 to 1625 879 to 112   AAA   768/895
(85 %)
30 diff
(96.7 %id)
BU685087 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 871 to 1619 766 to 19   AAA   748/748
(100 %)
2 diff
(99.8 %id)
AA312268   .d 872 to 1286 1 to 415       415/416
(99 %)
1 diff
(99.8 %id)
AW965803   .d 873 to 1446 1 to 574       574/577
(99 %)
4 diff
(99.4 %id)
CX754193 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 911 to 1613 732 to 30   AAA   703/703
(100 %)
5 diff
(99.3 %id)
BF663089 B-cells, primary B-cells from tonsils (cell line) .d 913 to 1594 1 to 682       682/683
(99 %)
9 diff
(98.7 %id)
BE794215 lung, small cell carcinoma .d 932 to 1678 1 to 743       743/743
(100 %)
6 diff
(99.2 %id)
BU680846 lung .d 937 to 1613 694 to 19   AAA   676/677
(99 %)
2 diff
(99.8 %id)
AA234285 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 938 to 1331 1 to 387       387/387
(100 %)
10 diff
(97.5 %id)
BI260925 cervical carcinoma cell line, cervix .d 1020 to 1714 1 to 694       694/694
(100 %)
5 diff
(99.3 %id)
BP209074 cerebellum .d 1029 to 1497 1 to 465       465/579
(80 %)
6 diff
(99.0 %id)
BX375456 Neuroblastoma Cot 25-normalized .d 1034 to 1568 533 to 1   fully sequenced,   533/533
(100 %)
11 diff
(98.0 %id)
W07468 lung .d 1051 to 1406 5 to 367   fully sequenced,   363/367
(98 %)
11 diff
(97.1 %id)
BF934195 nervous_tumor .d 1067 to 1357 289 to 4     Submitted on the opposite strand 286/291
(98 %)
0 diff
(100 %id)
BU623935 cell lines, Enchondroma .d 1096 to 1615 539 to 19   AAA   521/521
(100 %)
3 diff
(99.5 %id)
AI554705 anaplastic oligodendroglioma, brain .d 1132 to 1615 486 to 3       484/486
(99 %)
0 diff
(100 %id)
DB571527 hypothalamus .d 1144 to 1613 1 to 470     Submitted on the opposite strand 470/470
(100 %)
3 diff
(99.4 %id)
DB571093 hypothalamus .d 1145 to 1613 1 to 469     Submitted on the opposite strand 469/469
(100 %)
1 diff
(99.8 %id)
AA815072 germinal center B cell .d 1146 to 1619 482 to 10       473/482
(98 %)
0 diff
(100 %id)
Z43946 brain, total brain .d 1147 to 1468 1 to 320       320/320
(100 %)
5 diff
(98.5 %id)
R21068 whole brain .d 1148 to 1502 1 to 363       363/363
(100 %)
17 diff
(95.4 %id)
AI417556 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1149 to 1614 468 to 3       466/468
(99 %)
0 diff
(100 %id)
N99984 senescent fibroblast .d 1160 to 1619 445 to 2   fully sequenced,   444/445
(99 %)
41 diff
(90.8 %id)
CF140536 CNCAP(3)T-225 cell line, Prostate .d 1164 to 1485 1 to 322       322/322
(100 %)
4 diff
(98.8 %id)
CF140608 CNCAP(3)T-225 cell line, Prostate .d 1164 to 1483 1 to 320       320/321
(99 %)
4 diff
(98.8 %id)
DB553232 hypothalamus .d 1178 to 1613 1 to 439     Submitted on the opposite strand 439/441
(99 %)
22 diff
(95.1 %id)
AW083799 colon, moderately differentiated adenocarcinoma .d 1185 to 1615 438 to 8       431/438
(98 %)
0 diff
(100 %id)
AI659636 Prostate .d 1189 to 1615 429 to 3       427/429
(99 %)
0 diff
(100 %id)
AA579593 colon, colon tumor RER+ .d 1198 to 1614 416 to 1       416/416
(100 %)
7 diff
(98.4 %id)
CK820136 Islets of Langerhans, Pancreas .d 1199 to 1614 424 to 11   AAA   414/437
(94 %)
1 diff
(99.8 %id)
CK820137 Islets of Langerhans, Pancreas .d 1199 to 1614 12 to 425   AAA   414/425
(97 %)
6 diff
(98.6 %id)
BM354223 Islets of Langerhans, Pancreas .d 1204 to 1614 1 to 409   AAA   409/409
(100 %)
1 diff
(99.8 %id)
BX390748   .d 1208 to 2157 1 to 946       946/952
(99 %)
53 diff
(94.5 %id)
AW300771 colon, moderately differentiated adenocarcinoma .d 1211 to 1615 406 to 2       405/406
(99 %)
0 diff
(100 %id)
BF725557 eye, Iris .d 1214 to 1615 434 to 33   AAA   402/402
(100 %)
3 diff
(99.3 %id)
AA631570 lung, lung tumor .d 1228 to 1613 413 to 30   AAA   384/389
(98 %)
9 diff
(97.7 %id)
BM273228 Islets of Langerhans, Pancreas .d 1234 to 1611 388 to 13       376/388
(96 %)
0 diff
(100 %id)
BF445545 Prostate .d 1235 to 1613 379 to 1       379/379
(100 %)
0 diff
(100 %id)
BF740279 brain, oligodendroglioma .d 1236 to 1615 387 to 8       380/387
(98 %)
0 diff
(100 %id)
AA603742 normal prostate, Prostate .d 1246 to 1619 372 to 1       372/372
(100 %)
9 diff
(97.6 %id)
AA775930   .d 1268 to 1619 359 to 9       351/359
(97 %)
0 diff
(100 %id)
AI225088 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1272 to 1623 351 to 1       351/351
(100 %)
1 diff
(99.8 %id)
AI268725 carcinoid, lung .d 1274 to 1615 373 to 32   AAA   342/342
(100 %)
14 diff
(96.0 %id)
DB561499 hypothalamus .d 1292 to 1613 52 to 376     Submitted on the opposite strand 325/376
(86 %)
6 diff
(98.5 %id)
T19277   .d 1305 to 1613 311 to 1       311/311
(100 %)
11 diff
(96.5 %id)
BM991248 lung, Lung Focal Fibrosis .d 1309 to 1836 543 to 16   AAA   528/536
(98 %)
0 diff
(100 %id)
AI582709 anaplastic oligodendroglioma, brain .d 1310 to 1615 311 to 6       306/311
(98 %)
0 diff
(100 %id)
AA737439 germinal center B cell .d 1325 to 1619 302 to 10       293/302
(97 %)
0 diff
(100 %id)
R44722 whole brain .d 1326 to 1615 299 to 9       291/301
(96 %)
0 diff
(100 %id)
AA653416   .d 1331 to 1619 296 to 9       288/296
(97 %)
0 diff
(100 %id)
AA626281   .d 1372 to 1619 255 to 8       248/255
(97 %)
0 diff
(100 %id)
N81107 lung .d 1376 to 1619 245 to 1   fully sequenced,   245/245
(100 %)
7 diff
(97.2 %id)
AW188600 colon, moderately differentiated adenocarcinoma .d 1376 to 1619 248 to 5       244/248
(98 %)
0 diff
(100 %id)
AI283726 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1383 to 1622 240 to 1       240/240
(100 %)
0 diff
(100 %id)
AI864826 lymph node, lymphoma, follicular mixed small and largecell .d 1393 to 1615 254 to 32   AAA   223/223
(100 %)
7 diff
(96.9 %id)
AW016779   .d 1401 to 1575 176 to 2       175/176
(99 %)
0 diff
(100 %id)
AI468189 Prostate .d 1406 to 1615 210 to 1       210/213
(98 %)
0 diff
(100 %id)
AI810546 Prostate .d 1420 to 1614 199 to 5       195/199
(97 %)
0 diff
(100 %id)
Z41924 brain, total brain .d 1444 to 1725 1 to 281       281/281
(100 %)
5 diff
(98.3 %id)
BF436529 breast, invasive ductal carcinoma, 3 pooled samples .d 1448 to 1615 177 to 10       168/177
(94 %)
0 diff
(100 %id)
R18072 whole brain .d 1453 to 1775 10 to 333       324/333
(97 %)
13 diff
(96.1 %id)
R13108 whole brain .d 1502 to 1774 1 to 274       274/274
(100 %)
6 diff
(97.9 %id)
R10112 liver and spleen .d 1509 to 1613 121 to 17   AAA   105/105
(100 %)
3 diff
(97.2 %id)
BM017480 astrocytoma grade IV, cell line, brain .d 1514 to 2188 1 to 675       675/676
(99 %)
4 diff
(99.5 %id)
TI_59387982   .d 1514 to 2188 108 to 782       675/676
(99 %)
4 diff
(99.5 %id)
AA236275 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1523 to 1614 91 to 1       91/91
(100 %)
4 diff
(95.7 %id)
AL578011 placenta .d 1606 to 2553 944 to 4       941/944
(99 %)
0 diff
(100 %id)
BX384396   .d 1623 to 2528 904 to 5       900/904
(99 %)
0 diff
(100 %id)
BI519515 leukocyte .d 1724 to 2513 814 to 1       814/1065
(76 %)
39 diff
(96.4 %id)
TI_44459343   .d 1724 to 2513 814 to 1       814/1065
(76 %)
39 diff
(96.4 %id)
BP330321 rectum .d 1816 to 2400 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
DB361792 mammary gland .d 2013 to 2585 575 to 1       575/575
(100 %)
23 diff
(96.0 %id)
DB382450 thyroid gland .d 2047 to 2585 536 to 1       536/549
(97 %)
22 diff
(96.0 %id)
DB364584   .d 2053 to 2583 529 to 1       529/530
(99 %)
29 diff
(94.6 %id)
R40587 whole brain .d 2221 to 2585 382 to 11   AAA   372/458
(81 %)
8 diff
(98.3 %id)
R42967 whole brain .d 2305 to 2585 292 to 11   AAA   282/283
(99 %)
1 diff
(99.7 %id)
Z40003 brain, total brain .d 2307 to 2583 277 to 1       277/277
(100 %)
0 diff
(100 %id)
F01430 brain, total brain .d 2363 to 2585 223 to 1       223/223
(100 %)
0 diff
(100 %id)
AK297944   .e 1 to 1410 1 to 1411 G82R N121S tiling clone,   1411/1411
(100 %)
4 diff
(99.8 %id)
DC357630   .e 1 to 550 1 to 551 R28X A30C P31A A32G E33R ...     551/551
(100 %)
3 diff
(99.5 %id)
DC411766 kidney, tumor tissue .e 5 to 576 1 to 572 exact tiling clone,   572/572
(100 %)
1 diff
(99.9 %id)
BM544503 brain, hippocampus .f 1 to 1005 1 to 1015 exact tiling clone,   1015/1015
(100 %)
24 diff
(97.7 %id)
CR614517 Neuroblastoma Cot 10-normalized .f 64 to 1504 1 to 1441   tiling clone,   1441/1441
(100 %)
0 diff
(100 %id)
AL519610 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 64 to 897 1 to 828   fully sequenced,   828/828
(100 %)
2 diff
(99.8 %id)
AL519609 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 867 to 1504 626 to 1   fully sequenced,   626/626
(100 %)
3 diff
(99.6 %id)
CR623802 HeLa cells Cot 25-normalized .g 1 to 1472 1 to 1472 exact tiling clone,   1472/1472
(100 %)
0 diff
(100 %id)
AK056004   .h-u 1 to 2313 2 to 2314 A29V tiling clone, available from FLJ,   2314/2314
(100 %)
3 diff
(99.9 %id)
DA683570   .h-u 1 to 468 2 to 469   capped   468/468
(100 %)
0 diff
(100 %id)
DB322784   .h-u 1772 to 2313 543 to 1       543/543
(100 %)
1 diff
(99.9 %id)
DA463414   .i 1 to 322 2 to 323   tiling clone, capped   322/322
(100 %)
1 diff
(99.7 %id)
FJ423750   .i 1 to 246 1 to 248   tiling clone,   248/248
(100 %)
2 diff
(99.2 %id)
BM854368 stomach .i 2 to 181 1 to 180       180/180
(100 %)
2 diff
(98.9 %id)
BM857115 stomach .i 2 to 184 1 to 183       183/186
(98 %)
2 diff
(99.0 %id)
DA457637 tongue, tumor tissue .i 8 to 482 2 to 476   capped   475/475
(100 %)
4 diff
(99.2 %id)
DA673144   .i 179 to 682 89 to 592   tiling clone, capped   504/591
(85 %)
7 diff
(98.9 %id)
CX872326 embryonic stem .i 672 to 1391 1 to 719   tiling clone,   719/719
(100 %)
1 diff
(99.9 %id)
BF337191 brain, glioblastoma with EGFR amplification .i 816 to 1210 1 to 396       396/962
(41 %)
5 diff
(99.5 %id)
BF525635 brain, glioblastoma with EGFR amplification .i 944 to 1672 12 to 731       720/740
(97 %)
27 diff
(96.4 %id)
R50668 breast .i 947 to 1325 1 to 382       382/382
(100 %)
6 diff
(98.5 %id)
H45021 breast .i 947 to 1259 1 to 314       314/314
(100 %)
17 diff
(94.6 %id)
BG502042 embryonal carcinoma, testis .i 951 to 1465 1 to 516       516/517
(99 %)
3 diff
(99.5 %id)
BF838730 head_neck .i 1173 to 1371 1 to 201       201/221
(90 %)
3 diff
(98.7 %id)
BF933222 nervous_tumor .i 1173 to 1396 1 to 224       224/224
(100 %)
2 diff
(99.2 %id)
BE386751 melanotic melanoma, skin .i 1198 to 1857 20 to 677   available from MGC,   658/684
(96 %)
6 diff
(99.2 %id)
CB160031 Liver .i 1203 to 1701 24 to 522       499/522
(95 %)
6 diff
(98.9 %id)
BC042148 Skin, melanotic melanoma. .i 1204 to 2113 1 to 910   tiling clone, available from MGC, AAA   910/910
(100 %)
0 diff
(100 %id)
BE387026 melanotic melanoma, skin .i 1204 to 1627 28 to 448       421/448
(93 %)
6 diff
(98.7 %id)
BM727191 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i 1204 to 1598 10 to 403       394/403
(97 %)
1 diff
(99.8 %id)
H44968 breast .i 1677 to 2095 422 to 1       422/424
(99 %)
5 diff
(98.9 %id)
R50669 breast .i 1713 to 2111 411 to 1       411/413
(99 %)
18 diff
(95.7 %id)
BQ232037 embryonal carcinoma, cell line, testis .j 1 to 840 1 to 845 exact tiling clone,   845/874
(96 %)
9 diff
(99.0 %id)
BF804725 colon_ins .j 365 to 636 276 to 5     Submitted on the opposite strand 272/371
(73 %)
0 diff
(100 %id)
BI029468 marrow .j 423 to 740 1 to 318   tiling clone,   318/318
(100 %)
0 diff
(100 %id)
BQ221055 embryonal carcinoma, cell line, testis .k 1 to 717 1 to 723 exact tiling clone,   723/917
(78 %)
15 diff
(98.4 %id)
DA286725 corpus callosum .l 1 to 548 2 to 549 exact tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
AA226734 brain, neuroepithelial cells .l 32 to 383 2 to 353       351/353
(99 %)
8 diff
(97.8 %id)
BQ889073 dorsal root ganglia .l 35 to 795 1 to 763       763/967
(78 %)
13 diff
(98.7 %id)
BM010399 amelanotic melanoma, cell line, skin .l 44 to 696 1 to 651       651/651
(100 %)
12 diff
(98.2 %id)
TI_59385215   .l 44 to 696 94 to 744       651/651
(100 %)
12 diff
(98.2 %id)
CV023991 mixed .l 45 to 403 1 to 359       359/530
(67 %)
2 diff
(99.7 %id)
BM807640 amelanotic melanoma, cell line, skin .l 46 to 573 1 to 529       529/1174
(45 %)
20 diff
(98.3 %id)
BG331026 large cell carcinoma, lung .l 47 to 840 1 to 794       794/830
(95 %)
27 diff
(96.8 %id)
CN358431 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l 64 to 542 1 to 479       479/479
(100 %)
2 diff
(99.6 %id)
BI829779 brain, medulla .l 69 to 776 52 to 753       702/753
(93 %)
9 diff
(98.9 %id)
TI_57176344   .l 69 to 776 133 to 834       702/834
(84 %)
9 diff
(99.0 %id)
BF310107 muscle, rhabdomyosarcoma .l 79 to 787 1 to 703       703/840
(83 %)
20 diff
(97.7 %id)
BF206069 muscle, rhabdomyosarcoma .l 80 to 791 1 to 698       698/767
(91 %)
25 diff
(96.8 %id)
BE297507 muscle, rhabdomyosarcoma .l 81 to 584 1 to 504       504/504
(100 %)
0 diff
(100 %id)
BI758727 brain .l 84 to 783 1 to 705       705/708
(99 %)
12 diff
(98.4 %id)
TI_57220146   .l 84 to 783 1 to 705       705/708
(99 %)
12 diff
(98.4 %id)
BE297921 muscle, rhabdomyosarcoma .l 86 to 712 1 to 625       625/625
(100 %)
5 diff
(99.2 %id)
BF310095 muscle, rhabdomyosarcoma .l 92 to 674 1 to 582       582/1456
(39 %)
20 diff
(98.7 %id)
BX384397   .l 103 to 1144 1 to 1031   tiling clone,   1031/1031
(100 %)
23 diff
(97.8 %id)
BU844522 ovary, teratocarcinoma, cell line .l 124 to 990 1 to 873       873/920
(94 %)
16 diff
(98.3 %id)
BQ070444 brain, neuroblastoma, cell line .l 131 to 1084 1 to 973   tiling clone,   973/1038
(93 %)
37 diff
(96.5 %id)
BQ923285 epidermoid carcinoma, cell line, lung .l 141 to 961 1 to 834       834/926
(90 %)
25 diff
(97.4 %id)
BQ938800 epidermoid carcinoma, cell line, lung .l 141 to 947 1 to 820       820/997
(82 %)
30 diff
(97.0 %id)
BQ951739 epidermoid carcinoma, cell line, lung .l 141 to 674 1 to 535       535/853
(62 %)
11 diff
(98.8 %id)
CR982787 T-Lymphocytes .l 149 to 640 1 to 490       490/490
(100 %)
3 diff
(99.4 %id)
CR974895 T-Lymphocytes .l 149 to 568 1 to 421       421/421
(100 %)
1 diff
(99.8 %id)
CR981571 T-Lymphocytes .l 149 to 614 1 to 466       466/468
(99 %)
1 diff
(99.8 %id)
CR995508 T-Lymphocytes .l 149 to 466 1 to 318       318/321
(99 %)
1 diff
(99.7 %id)
CR993302 T-Lymphocytes .l 149 to 471 1 to 323       323/327
(98 %)
1 diff
(99.7 %id)
AA227441 brain, neuroepithelial cells .l 808 to 1265 456 to 2   tiling clone,   455/456
(99 %)
0 diff
(100 %id)
DA939662 Spleen .m 1 to 576 2 to 577 exact tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
DB119086 thymus .m 2 to 557 2 to 558 C53V A54R G55R R56Q G57R ... capped   557/557
(100 %)
2 diff
(99.7 %id)
TI_57220952   .m 5 to 815 63 to 876       814/876
(92 %)
21 diff
(97.7 %id)
AA323587 brain, cerebellum .m 10 to 233 1 to 224       224/224
(100 %)
1 diff
(99.6 %id)
BI756124 brain .m 11 to 815 1 to 808   tiling clone,   808/808
(100 %)
15 diff
(98.2 %id)
CX867988 embryonic stem .m 12 to 715 1 to 704   tiling clone,   704/704
(100 %)
0 diff
(100 %id)
BM548297 brain, hippocampus .m 21 to 559 21 to 559       539/1251
(43 %)
17 diff
(98.7 %id)
BU186623 large cell carcinoma, lung .m 28 to 812 1 to 789   tiling clone,   789/924
(85 %)
11 diff
(98.9 %id)
CX867912 embryonic stem .m 769 to 1292 551 to 28   tiling clone, AAA   524/524
(100 %)
2 diff
(99.7 %id)
AK093985 uterus .n 1 to 2131 1 to 2131 exact tiling clone, available from FLJ,   2131/2131
(100 %)
1 diff
(100.0 %id)
AX748394   .n 1 to 2131 1 to 2131 exact     2131/2131
(100 %)
1 diff
(100.0 %id)
DB249761 uterus .n 2 to 502 2 to 505   capped   504/504
(100 %)
4 diff
(99.3 %id)
BG388486 embryonal carcinoma, cell line, testis .n 1360 to 1965 1 to 610       610/910
(67 %)
18 diff
(98.1 %id)
BE395526 endometrium, adenocarcinoma cell line, uterus .n 1490 to 2049 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
CN358429 embryonic stem cells, cell lines H1, H7, andH9 .n 1500 to 2009 1 to 510       510/510
(100 %)
5 diff
(99.1 %id)
BG282879 adenocarcinoma, cell line, Prostate .n 1581 to 2133 1 to 552   AAA   552/552
(100 %)
6 diff
(99.0 %id)
CA306188 Alveolar Macrophage, lung .n 1591 to 2131 560 to 19   AAA   542/542
(100 %)
13 diff
(97.7 %id)
DB351037 uterus .n 1602 to 2131 530 to 1       530/531
(99 %)
0 diff
(100 %id)
BX105564 whole brain .n 1653 to 2133 495 to 15   AAA   481/481
(100 %)
0 diff
(100 %id)
AI692474 carcinoid, lung .n 1665 to 2134 472 to 3       470/472
(99 %)
0 diff
(100 %id)
AI921515 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 1693 to 2131 461 to 22   AAA   440/440
(100 %)
6 diff
(98.7 %id)
AI569235 anaplastic oligodendroglioma, brain .n 1707 to 2131 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
AW028251 thymus, pooled .n 1709 to 2133 438 to 15   AAA   424/424
(100 %)
13 diff
(97.0 %id)
AI983962 colon, colonic mucosa from 3 patients with Crohn'sdisease .n 1754 to 2131 391 to 14   AAA   378/378
(100 %)
4 diff
(99.0 %id)
AI383868 B-cell, chronic lymphotic leukemia .n 1763 to 2133 365 to 1       365/365
(100 %)
19 diff
(94.8 %id)
AW050925 colon, colonic mucosa from 3 patients with Crohn'sdisease .n 1816 to 2131 332 to 13   AAA   320/320
(100 %)
15 diff
(95.4 %id)
CD251068 brain, Pituitary .n 1845 to 2133 1 to 289   AAA   289/289
(100 %)
0 diff
(100 %id)
AA833636   .n 2017 to 2134 120 to 3       118/120
(98 %)
0 diff
(100 %id)
DR978320 brain .n 2091 to 2363 272 to 1   tiling clone,   272/282
(96 %)
2 diff
(99.3 %id)
DR978347 brain .n 2093 to 2363 270 to 1   tiling clone,   270/280
(96 %)
7 diff
(97.5 %id)
DR978236 brain .n 2096 to 2363 266 to 1   tiling clone,   266/275
(96 %)
5 diff
(98.2 %id)
DR978367 brain .n 2096 to 2363 267 to 1   tiling clone,   267/276
(96 %)
3 diff
(99.0 %id)
BF956594 nervous_normal .n 2185 to 2346 24 to 185       162/196
(82 %)
3 diff
(98.5 %id)
BU535785 mixed (pool of 40 RNAs) .o 1 to 353 4 to 356 exact tiling clone, AAA   356/356
(100 %)
4 diff
(98.9 %id)
AI355205 esophagus, squamous cell carcinoma .p 1 to 492 491 to 1 R50G K51R V52* tiling clone,   491/491
(100 %)
1 diff
(99.8 %id)
DA961520 Spleen .q 1 to 569 6 to 575 C45V A46R G47R R48Q G49R ... tiling clone, capped   574/574
(100 %)
2 diff
(99.7 %id)
DA616137   .r 1 to 581 2 to 582 E44G C71R tiling clone, capped   581/581
(100 %)
2 diff
(99.7 %id)
CB125045 Liver .r 15 to 588 1 to 575 E44G     575/575
(100 %)
5 diff
(99.2 %id)
DB203755 trachea .r 15 to 585 2 to 572 E44G G46E T74A capped   571/571
(100 %)
4 diff
(99.3 %id)
TI_57217263   .r 18 to 892 33 to 905 E44G     873/984
(88 %)
13 diff
(98.7 %id)
BI754631 brain .r 19 to 892 1 to 872 E44G tiling clone,   872/951
(91 %)
13 diff
(98.7 %id)
BX401041   .r 24 to 712 1 to 680 E44G S85A fully sequenced,   680/680
(100 %)
2 diff
(99.8 %id)
BI059491 uterus_tumor .r 228 to 448 1 to 221       221/221
(100 %)
0 diff
(100 %id)
BI061865 uterus_tumor .r 228 to 448 1 to 221       221/221
(100 %)
0 diff
(100 %id)
BF843062 head_neck .r 381 to 541 1 to 161       161/161
(100 %)
1 diff
(99.4 %id)
BX401040   .r 682 to 1495 794 to 1   tiling clone, fully sequenced,   794/794
(100 %)
10 diff
(98.8 %id)
BE266179 lung, small cell carcinoma .s 1 to 637 1 to 640 exact tiling clone, AAA   640/691
(92 %)
14 diff
(98.0 %id)
TI_154062121   .s 21 to 855 926 to 103 S3P L4A A5S R6I P7L ... AAA   824/991
(83 %)
19 diff
(98.1 %id)
BM703210 eye, human retina .s 110 to 492 1 to 383   fully sequenced,   383/383
(100 %)
1 diff
(99.8 %id)
BM684899 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .s 128 to 857 748 to 19   AAA   730/734
(99 %)
1 diff
(99.9 %id)
TI_151790018   .s 128 to 729 68 to 672       605/836
(72 %)
10 diff
(98.9 %id)
BE311452 Kidney, renal cell adenocarcinoma .s 181 to 793 1 to 622       622/731
(85 %)
19 diff
(97.5 %id)
BE273152 Kidney, renal cell adenocarcinoma .s 181 to 682 1 to 502       502/504
(99 %)
4 diff
(99.3 %id)
TI_151726938   .s 192 to 855 796 to 128   AAA   669/669
(100 %)
14 diff
(98.0 %id)
CA421024 Bone, Enchondroma cell line .s 226 to 855 648 to 19   AAA   630/630
(100 %)
1 diff
(99.9 %id)
CR591126 T cells (Jurkat cell line) Cot10-normalized .s 231 to 863 1 to 633   tiling clone,   633/633
(100 %)
0 diff
(100 %id)
BX341002   .s 231 to 863 1 to 639       639/639
(100 %)
6 diff
(99.1 %id)
AW363795 colon .s 293 to 548 1 to 255       255/264
(96 %)
8 diff
(97.0 %id)
BI199973 brain, neuroblastoma .s 342 to 720 1 to 379       379/380
(99 %)
3 diff
(99.3 %id)
BE262551 brain, neuroblastoma .s 344 to 854 16 to 525   AAA   510/525
(97 %)
6 diff
(98.9 %id)
BE262389 brain, neuroblastoma .s 363 to 856 1 to 499       499/661
(75 %)
5 diff
(99.3 %id)
AW612595 Kidney .s 389 to 836 458 to 1       458/458
(100 %)
10 diff
(97.9 %id)
AI554649 anaplastic oligodendroglioma, brain .s 402 to 838 455 to 19   AAA   437/437
(100 %)
3 diff
(99.4 %id)
AI422305 brain, glioblastoma (pooled) .s 413 to 862 458 to 1       458/458
(100 %)
4 diff
(99.2 %id)
AI433337 Kidney .s 437 to 855 429 to 1       429/429
(100 %)
9 diff
(98.0 %id)
BM664702 eye, human retina .s 462 to 855 423 to 19   fully sequenced, AAA   405/405
(100 %)
8 diff
(98.1 %id)
BF906320 ovary .s 466 to 614 1 to 148       148/184
(80 %)
6 diff
(96.8 %id)
BF906349 ovary .s 466 to 614 1 to 148       148/184
(80 %)
6 diff
(96.8 %id)
AI160234 brain, glioblastoma (pooled) .s 466 to 838 385 to 3       383/385
(99 %)
0 diff
(100 %id)
AI250867 lymph node, lymphoma, follicular mixed small and largecell .s 466 to 858 404 to 2       403/404
(99 %)
0 diff
(100 %id)
AW515560 Kidney, renal cell tumor .s 469 to 839 373 to 3       371/373
(99 %)
0 diff
(100 %id)
AW515773 pooled germ cell tumors .s 534 to 855 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AI672302 Kidney .s 541 to 857 327 to 1       327/327
(100 %)
8 diff
(97.6 %id)
AI870048 colon, colonic mucosa from 3 patients with Crohn'sdisease .s 630 to 856 227 to 1       227/234
(97 %)
1 diff
(99.6 %id)
AW051623 Kidney .s 630 to 855 226 to 1       226/236
(95 %)
2 diff
(99.2 %id)
W88425 liver and spleen .s 639 to 1002 363 to 1   tiling clone,   363/363
(100 %)
2 diff
(99.5 %id)
BI760670 pooled colon, kidney, stomach .t 1 to 452 1 to 452 exact tiling clone,   452/634
(71 %)
3 diff
(99.6 %id)
TI_57147815   .t 1 to 452 36 to 487 exact     452/669
(67 %)
7 diff
(99.0 %id)
BP205613 coronary artery Gene C19orf25, variant not shown         Suspected internal deletion, this clone was ignored    
DA445157 tongue, tumor tissue Gene C19orf25, variant not shown       capped This clone was ignored    
BC071633 Blood, adult leukocytes Gene C19orf25, variant not shown       available from MGC, AAA This clone was ignored    
BI907147 leukocyte Gene C19orf25, variant not shown       available from MGC, This clone was ignored    
CB995192 placenta, pre-eclamptic placenta Gene C19orf25, variant not shown         Suspected internal deletion, this clone was ignored    
TI_57233514   Gene C19orf25, variant not shown         This clone was ignored    
TI_154196433   Gene C19orf25, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b-u, .c-u, .d, .e, .f, .g, .h-u, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI